Company: SGBAF
Filing Date: 2025-04-23
Form Type: DRS/A
Source: 0000950123-25-003652
Chunk: 699

Company: SES S.A.
Filing Date: 2025-04-23
Form: DRS/A
Chunk 699
---
, that each of the undersigned constitutes and appoints Sandeep Jalan and Thai Rubin, acting alone, his or her true and lawful attorney-in-factand agent, with full power of substitution and resubstitution, for such person and in his or her name, place and stead, in any and all capacities, to sign this Amendment No. 3 to the Registration Statement on Form F-4,or other appropriate form, and all amendments thereto, including post-effective amendments, of SES, and to file the same, with all exhibits thereto, and other document in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-factand agent, acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming that any such attorney-in-factand agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.

| Signature           |     | Title                                                              |     |   Date |
| Adel Al-Saleh       |     | Chief Executive Officer (Principal Executive Officer)              |     | , 2025 |
| Sandeep Jalan       |     | Chief Financial Officer (Principal Financial Officer and Principal 
 Accounting Officer)                                                |     | , 2025 |
| Frank Esser         |     | Chairman of the Board                                              |     | , 2025 |
| Anne-Catherine Ries |     | Director                                                           |     | , 2025 |
| Peter van Bommel    |     | Director                                                           |     | , 2025 |
| Carlo Fassbinder    |     | Director                                                           |     | , 2025 |

II-5

Confidential Treatment Requested by SES Pursuant to 17 C.F.R. Section 200.83

| Signature          |     | Title    |     |   Date |
| Kaj-Erik Relander  |     | Director |     | , 2025 |
| Katrin Wehr-Seiter |     | Director |     | , 2025 |
| Jacques Thill      |     | Director |     | , 2025 |
| Françoise Th